Roche Venture Fund Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 4

Professionals

  • Investments
  • 171

  • Portfolio
  • 29

  • Exits
  • 99

Exits

Roche Venture Fund General Information

Company Description

Founded in 2002, Roche Venture Fund is the corporate venture capital arm of Roche Holding based in Basel, Switzerland. The firm prefers to make investments in early-stage life science companies operating in the pharmaceuticals and diagnostics sectors.

Business Details

Year Founded
2002
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Corporate Office
  • Grenzacherstrasse 124
  • 4070 Basel
  • Switzerland

Roche Venture Fund Investments (171)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Mission Therapeutics 14-Mar-2024 Later Stage VC 000.00 Drug Discovery Clinical Trials - Phase 2 000000 000000000000 00
Freenome 15-Feb-2024 00000 00000 00000 Decision/Risk Analysis Clinical Trials - General
Cour 30-Jan-2024 00000 00000 00000 Biotechnology Generating Revenue
NMD Pharma 15-Nov-2023 00000 00000 000.00 Biotechnology Clinical Trials - Phase 2 00000 00000
Mironid 13-Sep-2023 00000 00000 000.00 Therapeutic Devices Generating Revenue
Diogenx 01-Mar-2023 00000 00000 000.00 Drug Discovery Generating Revenue 00000 00000
Bonum Therapeutics 15-Nov-2022 00000 00000 0000 Drug Discovery Generating Revenue 0000000 0000000000 00.0
Thelium Therapeutics 20-Apr-2022 0000 00000 0000 Pharmaceuticals Out of Business
NMD Pharma 15-Feb-2022 Later Stage VC 000.00 Biotechnology Clinical Trials - Phase 2 0000000 0000000000 00.0
Freenome 11-Jan-2022 Later Stage VC 00000 Decision/Risk Analysis Clinical Trials - General
You’re viewing 10 of 171 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Roche Venture Fund Exits (99)

Company Name Exit Date Exit Type Exit Size
Enliven Therapeutics 23-Feb-2023 Reverse Merger
Lino Biotech 22-Feb-2023 000000000000000000
Thelium Therapeutics 06-Jan-2023 000 00 00000000
Purigen Biosystems 30-Nov-2022 000000000000000000 000.00
Good Therapeutics 18-Aug-2022 000000000000000000 00000
MacuLogix 26-Jul-2022 000000000000000000
BlueLight Therapeutics 04-Nov-2021 000 00 00000000
Entrada Therapeutics 02-Nov-2021 000 00000
BCTG Acquisition 10-Aug-2021 Merger/Acquisition
Aligos Therapeutics 01-Jul-2021 Public Investment 2nd Offering 000.00
You’re viewing 10 of 99 exits. Get the full list »

Roche Venture Fund Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Roche Venture Fund Management, Team & Partners (13)

Name Title Deals Funds Boards Office
Carole Nuechterlein JD Head, Roche Venture Fund 00 0 0 Basel, Switzerland
David Evans Investment Director 0 0 0 Basel, Switzerland
Nisha Marathe Ph.D Investment Director 0 0 0 Basel, Switzerland
Simon Greenwood Ph.D Senior Investment Director 0 0 0 Basel, Switzerland
Gabriella Zöch Project Manager Basel, Switzerland
You’re viewing 5 of 13 team members. Get the full list »

Roche Venture Fund Co-Investors (176)

Name With Exits Lead Partner Series Industry
Boxer Capital 5 0 0 Series chart Industry bar
Cormorant Asset Management 0 0 Series chart Industry bar
Janus Henderson Investors 0 0 Series chart Industry bar
Sofinnova Partners 0 0 Series chart Industry bar
5AM Ventures 0 0 Series chart Industry bar
You’re viewing 5 of 176 co-investors. Get the full list »

Roche Venture Fund FAQs

  • What is Roche Venture Fund?

    Founded in 2002, Roche Venture Fund is the corporate venture capital arm of Roche Holding based in Basel, Switzerland.

  • When was Roche Venture Fund founded?

    Roche Venture Fund was founded in 2002.

  • Where is Roche Venture Fund headquartered?

    Roche Venture Fund is headquartered in Basel, Switzerland.

  • What is Roche Venture Fund's total asset value?

    Roche Venture Fund has around 00000 in total assets under management.

  • How many investments has Roche Venture Fund made?

    Roche Venture Fund has made 171 investments.

  • What has Roche Venture Fund invested in?

    Roche Venture Fund has made numerous investments in companies like Mission Therapeutics, Freenome, and Cour within the Drug Discovery, Decision/Risk Analysis, and Biotechnology industries.

  • What has Roche Venture Fund invested in recently?

    Roche Venture Fund's latest investment was on 14-Mar-2024 in Mission Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »